Highest-materiality recent filing
Quaker Houghton Q2 2026: net sales +10% to $532.6M, non-GAAP EPS $2.19 (+28% YoY)
Net sales $532.6M (+10% YoY); GAAP EPS $1.55 vs loss $3.78; non-GAAP EPS $2.19 (+28%).
Quaker Houghton VP & Principal Accounting Officer Steven Dassing resigns; CFO Coler to assume role
Steven Dassing resigns as VP, Corporate Controller and Principal Accounting Officer effective July 22, 2026 to pursue another career opportunity.
Quaker Houghton names Mark Douglas Chairman; Michael Barry retires after 18 years
Michael F. Barry retired as Chairman and director on May 13, 2026 after 18 years on Board, 17 as Chairman.
Quaker Houghton Q1 net sales up 8% to $480.5M; non-GAAP EPS $1.63, up 3% Y/Y
Net sales $480.5M (+8% Y/Y); organic volumes up 3% driven by ~4% new business wins.
Quaker Chemical Amends Credit Agreement, Secures $1.6B in New Facilities
Entered into Amendment No. 4 to credit agreement on April 10, 2026, with $550M U.S. term loan, $250M euro term loan, and $800M revolving credit facility.
Quaker Houghton SVP & Chief Global Operations Officer Jeff Fleck Departs Involuntarily
Jeffrey Fleck no longer serves as SVP, Chief Global Operations Officer effective March 9, 2026.
Quaker Houghton reports Q4 net sales $468.5M (+6% Y/Y); FY2025 net loss $2.5M due to impairment
Q4 net income $20.7M ($1.18 diluted EPS); non-GAAP EPS $1.65, up 24% Y/Y.
Quaker Houghton Q3 net sales +7% to $493.8M; adj. EPS $2.08 (+10% YoY); leverage reduced to 2.4x
Q3 net sales $493.8M (+7% YoY) driven by organic volume +3% and acquisitions +5%; price/mix -2%.
Quaker Houghton reports Q2 net loss of $66.6M on $88.8M impairment; adjusted EPS $1.71 vs $2.13
Q2 net sales $483.4M (+4% Y/Y); organic volumes +2% on new business wins of ~5%.
Jeff Kutz resigns as CAO; Steve Dassing appointed Principal Accounting Officer at Quaker Chemical
Jeff Kutz resigned as Chief Accounting Officer effective July 18, 2025; departure voluntary, no disagreement with Company.
Director Ramaswami Seshasayee retires from Quaker Chemical board; size reduced to 11
Ramaswami Seshasayee retired from the Board effective May 14, 2025, after serving since 2019.
Directors elected: Mark A. Douglas, Sanjay Hinduja, William H. Osborne, Fay West (three-year terms).
Net sales $442.9M, down 6% YoY; net income $12.9M ($0.73 diluted) vs $35.2M ($1.95) in Q1 2024.
Quaker Houghton closes two acquisitions: Dipsol ($153M) and Natech ($5.2M)
Completed acquisition of Dipsol Chemicals for 23B JPY (~$153M); multiple ~10.5x trailing EBITDA of ~$15M.
Quaker Houghton acquires Dipsol Chemicals for ~$153M (23B JPY) to expand advanced solutions
Purchase price ~$153M (23B JPY); ~10.5x Dipsol's trailing 12-month adjusted EBITDA of ~$15M.
Quaker Houghton Q4 net sales down 5% to $444M; adj. EPS drops to $1.33
Q4 net sales $444.1M, down 5% YoY; net income $14.2M ($0.81 diluted EPS) vs $20.2M ($1.12) prior year.
Quaker Chemical awards 5,565 RSUs to CFO Tom Coler and 4,255 RSUs to CSO Jeewat Bijlani
Target RSU awards: Tom Coler (CFO) 5,565 RSUs, Jeewat Bijlani (CSO) 4,255 RSUs.
Quaker Chemical finalizes CEO Tometich's severance; 18 months pay, accelerated equity vesting
Tometich departed Nov 18, 2024; agreement signed Dec 5, 2024 includes 18 months bi-weekly severance at current rate plus prorated AIP at 100% individual target.
Quaker Houghton's SVP & Chief HR Officer Melissa Leneis departs Dec 2, 2024
Melissa Leneis no longer serves as SVP & Chief HR Officer as of December 2, 2024.
Quaker Houghton appoints Joseph Berquist as CEO, replacing Andy Tometich
Joseph Berquist appointed CEO and President effective Nov 18, 2024; also elected to Board as Class I director.
Quaker Houghton Q3 net sales down 6% to $462.3M; non-GAAP EPS $1.89 vs $2.05
Net sales $462.3M, down 6% YoY; net income $32.3M ($1.81 diluted EPS) from $33.7M ($1.87).
Quaker Houghton Q2 net sales $463.6M (-6%); EPS $1.94; adj. EPS $2.13; EBITDA up 5%; dividend +6.6%
Net sales $463.6M, down 6% YoY due to index-based pricing (-4%) and slight volume decline (-1%).
Quaker Houghton appoints Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder to board
Board expanded from 10 to 12 directors; both appointed as independent members effective July 31, 2024.
Shareholders approve 2024 Long-Term Performance Incentive Plan, adding 900K shares for equity awards
Restated Plan approved with ~12.8M For, ~3.3M Against; adds 900K shares to share pool (plus remaining 2016 Plan shares).
Quaker Houghton appoints Tom Coler as CFO effective June 10, 2024; Shane Hostetter departs
Shane Hostetter terminated as CFO effective June 7, 2024; will remain in transition role through August 4, 2024.
Quaker Chemical (KWR) Q1 2024 net sales $469.8M (-6% YoY); adj. EBITDA up 6% to $83.3M
GAAP diluted EPS $1.95 vs $1.64 prior year; non-GAAP EPS $2.09 vs $1.89.
Quaker Houghton Q4 net sales $467M, EPS $1.12; adj EBITDA up 13%, initiates $150M buyback
Q4 net sales $467.1M (-4% YoY); GAAP EPS $1.12; non-GAAP EPS $1.78.
Quaker Houghton appoints Jeffrey Kutz as VP, Chief Accounting Officer effective Nov 30, 2023
Kutz to assume CAO role from Shane Hostetter (remains EVP & CFO); employment starts Jan 2, 2024.
Quaker Houghton posts Q3 net income $33.7M, adjusted EBITDA up 20% YoY to $84.4M
Q3 net sales $490.6M, flat YoY; volume down 4% offset by price/mix up 2% and FX 2%.
Quaker Houghton CAO David Will resigns; CFO Hostetter adds CAO duties
David A. Will resigns as VP & Chief Accounting Officer effective Oct 2, 2023.
Quaker Chemical corrects auditor consent filing for omitted registration statements
Corrected Consent now references omitted S-3 and S-8 registration statements.
Quaker Chemical files annual report without press release; no earnings summary provided
Filing contains XBRL financials for 2020-2022 but no plain-English earnings release.
Quaker Houghton Q2 2023 net sales $495.4M, adj. EBITDA $80.2M up 37% YoY
Net income $29.3M ($1.63 diluted EPS) vs $14.3M ($0.80) YoY; non-GAAP EPS $1.93.
Quaker Chemical adds Russell R. Shaller (CEO of Brady Corp) to its Board
Board size increased to 11; Shaller elected as Class II director (term expires 2024).
Shareholders elected Charlotte C. Decker, Ramaswami Seshasayee, and Andrew E. Tometich as directors with terms until 2026.
Quaker Houghton Q1 net sales record $500.1M, adjusted EBITDA up 30% YoY
Net sales $500.1M (+5% YoY) driven by 19% price/mix; volumes down 11% due to softer markets and Ukraine war.
Quaker Houghton Q4 net loss $76M on $93M goodwill impairment; non-GAAP EPS $1.39
Q4 net sales $484.8M (+8% YoY) driven by 24% price/mix; volumes down 10%.
Quaker Chemical adopts amended bylaws with updated director nomination and proxy rules
New bylaw requires shareholder director nominations to include Rule 14a-19 compliance representation.
Quaker Houghton Q3 GAAP EPS $1.44, down from $1.73; net sales up 10% to $492M
GAAP net income $25.9M ($1.44 diluted EPS) vs $31.1M ($1.73) in Q3 2021.
Quaker Houghton appoints Berquist CCO, Bijlani CSO; Bijlani comp increased
Joseph Berquist named Chief Commercial Officer effective Jan 1, 2023; no change to his compensation.
Quaker Houghton Q2 record sales $492.4M (+13%), net income drops to $14.3M; adjusted EBITDA $58.5M
Record net sales of $492.4M, up 13% YoY, driven by 22% price/mix increase partially offset by 4% volume decline and 6% FX headwind.
Quaker Chemical refinances credit facilities with $1.25B in new loans and revolver
New facilities: $150M euro term loan, $600M USD term loan, $500M revolver; matures June 17, 2027.
Quaker Chemical shareholders elect four directors and ratify PwC as auditor for FY2022
Elected directors Mark A. Douglas, Sanjay Hinduja, William H. Osborne, Fay West to three-year terms expiring 2025.
Quaker Houghton Q1 net sales record $474.2M, but EPS down 48% to $1.11; adj. EBITDA falls 22%
Record net sales of $474.2M, up 10% YoY; selling prices rose 17% but organic volumes fell 6%.
Q4 net sales $447.0M (+16%); net income $18.1M ($1.01 EPS) vs $48.5M ($2.72) YoY.
Quaker Houghton reports record Q3 2021 net sales of $449.1M, net income $31.1M
Net sales rose 22% to $449.1M vs Q3 2020, driven by 10% organic volume growth and price/mix gains of 10%
Quaker Houghton appoints Andrew Tometich as CEO effective Dec 1; Barry accelerates retirement
Andrew Tometich appointed CEO and President, effective Dec 1, 2021; expected start in early Oct 2021.
Net sales of $435.3M increased 52% YoY; net income of $33.6M vs net loss of $7.7M in Q2 2020.
On June 30, 2026, Steven Dassing resigned from his position as Vice President, Corporate Controller and Principal Accounting Officer of Quaker Chemical Corporation (“Quaker Houghton” or the “Company”) effective July 22, 2026.
Upon the effectiveness of Mr. Dassing’s resignation, Mr. Coler, age 53, will serve as the Company’s Principal Accounting Officer, in addition to his current position as Executive Vice President, Chief Financial Officer.
the Board appointed Mr. Mark A. Douglas, an independent director who has served on the Board since 2013, to succeed Mr. Barry as Chairman.
Mr. Michael F. Barry, a member of the Board of Directors (the “Board”) of Quaker Chemical Corporation (the “Company”) notified the Company of his retirement from the Board, effective at the conclusion of the Board meeting on May 13, 2026.
On May 14, 2025, Mr. Ramaswami Seshasayee, a member of the Board of Directors (the “Board”) of Quaker Chemical Corporation (“the Company”) notified the Company of his retirement from the Board, effective on such date.
Additionally, effective as of November 18, 2024, Andrew E. Tometich no longer serves as the Company’s Chief Executive Officer and President or as a member of the Board.
On November 14, 2024, the Board of Directors (the “Board”) of Quaker Chemical Corporation (the “Company”), appointed Joseph A. Berquist, age 53, the Company’s Chief Commercial Officer, to serve as Chief Executive Officer and President, effective November 18, 2024.
elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.
elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.
On May 9, 2024, Quaker Chemical Corporation (the “Company”) announced the termination of the employment of Shane Hostetter, as the Company’s Chief Financial Officer, effective as of June 7, 2024.
On May 6, 2024, the Board of Directors of the Company appointed Tom Coler, age 50, to Executive Vice President and Chief Financial Officer, effective June 10, 2024.
a role he will assume from Shane Hostetter who has served as Chief Accounting Officer since October 2, 2023, in addition to his continuing role as Executive Vice President, Chief Financial Officer.
Max materiality 0.90 · Median 0.70 · Most common event earnings